NeuDefense is a pioneering behavioral health and legal platform that leverages advanced genetics and neuroscience I to transform how we understand and defend human behavior. At the core of NeuDefense is Predict IQ, a patented genetic test that identifies predispositions related to addiction, impulsivity, OCD, and mood imbalances often overlooked in traditional legal and clinical systems.
We specialize in using scientifically validated genetic insights to support personalized interventions, legal defense strategies, and evidence-based risk assessments. Whether applied in courtrooms, recovery programs, or clinical settings, our technology gives voice to the underlying neurobiological factors that shape behavior,offering a powerful tool for mitigation, treatment planning, and justice reform.
NeuDefense empowers legal teams, behavioral health providers, and policymakers with actionable data to advocate for clients, reduce recidivism, and promote outcomes grounded in science, not stigma.
Mission:
To advance human justice and recovery through genetic truth, data-driven insights, and compassionate technology.
Available Through:
At-home or provider-facilitated DNA testing
Digital AI-generated behavioral profiles
Expert consulting for legal, clinical, and recovery professionals
NeuDefense is where behavioral science meets legal innovation, redefining responsibility, recovery, and rehabilitation in the age of precision justice.
Meet the Team
Richard Paul Green III, BSBA, LCDC
Founder & Executive Director
Rick Green is a veteran executive and clinician with over 30 years of experience spanning addiction medicine, pharmaceutical innovation, forensic consulting, and legal strategy. He’s held leadership roles at Genzyme, Pfizer, Sanofi, and Geneus Health, and now serves as CEO of Precision Recovery, a top medically integrated rehab program supporting individuals facing felony DUI charges or licensing issues.
As a licensed chemical dependency counselor, Rick has delivered behavioral health services across outpatient, residential, and detox settings since 2014. He combines clinical expertise with a background in pharmaceutical development and has published on genetic addiction risk, dopamine regulation, and MAT policy. He frequently presents at national conferences and advises courts as an expert witness on forensic testing and substance use disorders.
Rick pioneered NeuDefense and co-developed Predict IQ the first genetic test used in DUI/SUD defense, marking a breakthrough in legal-health integration. He consults with attorneys, pharma companies, and treatment organizations, and has served on the NAADAC Public Policy Committee and other state-level advisory boards.
Expertise Highlights:
- CEO, Precision Recovery
- 30+ years in addiction, pharma, and legal-health innovation
- Licensed counselor and expert witness in DUI defense
- Creator of Predict IQ genetic legal tool
- Former executive at Genzyme, Pfizer, and Sanofi
- Advocate and educator in neuroscience-based recovery solutions
Our Clinical and Legal Team
Dr. Vidhya Narayanan, PhD
Genetic Director
Leads research and development, ensuring NeuDefense’s methods are scientifically sound and effective.
Maria Rodriguez, LCSW
Director of Rehabilitation
Oversees the Synapta+ program and outpatient treatment, ensuring personalized and effective recovery plans.
Jameson Davies
Lead Legal Strategist
Develops and implements legal strategies, leveraging genetic evidence to support clients’ defense.
Dr. James Jones, MD
Medical Advisor
Provides medical expertise and guidance, ensuring the safety and efficacy of NeuDefense’s treatment protocols.
